| The relevance of monoclonal antibodies in the treatment of COVID-19 A Torrente-López, J Hermosilla, N Navas, L Cuadros-Rodríguez, ... Vaccines 9 (6), 557, 2021 | 17 | 2021 |
| Comprehensive analysis of nivolumab, a therapeutic anti-Pd-1 monoclonal antibody: impact of handling and stress A Torrente-López, J Hermosilla, A Salmerón-García, J Cabeza, N Navas Pharmaceutics 14 (4), 692, 2022 | 12 | 2022 |
| Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes N Navas, J Hermosilla, A Torrente-López, J Hernández-Jiménez, ... Journal of Pharmaceutical Analysis 10 (6), 532-545, 2020 | 12 | 2020 |
| QbD/PAT—State of the art of multivariate methodologies in food and food-related biotech industries CH Pérez-Beltrán, AM Jiménez-Carvelo, A Torrente-López, NA Navas, ... Food Engineering Reviews 15 (1), 24-40, 2023 | 6 | 2023 |
| Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing R Pérez-Robles, A Salmerón-García, J Hermosilla, A Torrente-López, ... European Journal of Pharmaceutics and Biopharmaceutics 184, 103-115, 2023 | 5 | 2023 |
| Comprehensive physicochemical and functional analysis of pembrolizumab based on controlled degradation studies: Impact on antigen–antibody binding A Torrente-López, J Hermosilla, A Salmerón-García, J Cabeza, ... European Journal of Pharmaceutics and Biopharmaceutics 194, 131-147, 2024 | 3 | 2024 |
| Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and isoforms identification of intact nivolumab A Torrente-López, J Hermosilla, R Pérez-Robles, A Salmeron-Garcia, ... Microchemical Journal 182, 107896, 2022 | 1 | 2022 |
| Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding A Torres-García, A Torrente-López, J Hermosilla, A Hernández, ... Pharmaceutics 16 (9), 1222, 2024 | | 2024 |
| 3PC-009 The effect of accelerated light (stress) and natural sunlight exposures on cetuximab (Erbitux®): evaluation of aggregate formation and functionality A Torres-García, A Torrente-López, J Hermosilla, A Aguilera-Ortega, ... European Journal of Hospital Pharmacy 31 (Suppl 1), A32-A33, 2024 | | 2024 |
| Divulgación de los TFMs del Máster en Investigación, Desarrollo, Control e Innovación de Medicamentos a través del BlogUGR ‘Divulgando ciencia’ A Torrente López | | 2023 |
| 3PC-017 Impact of agitation on pembrolizumab (Keytruda®) safety and efficacy: aggregation and functionality A Torrente-López, R Pérez-Robles, J Hermosilla, J Ruiz-Travé, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A18-A18, 2023 | | 2023 |
| 5PSQ-067 Tracking the overal in use and stress stability of romiplistim (n-plate®) by the evaluation of a selected set of critical quality attributes R Pérez-Robles, J Ruiz-Travé, M Martinez, J Hermosilla, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A135-A135, 2023 | | 2023 |
| In-use stability of the therapeutic monoclonal antibodies Tocilizumab, Nivolumab and Pembrolizumab: Comprehensive analysis of physicochemical parameters and functionality A Torrente López Universidad de Granada, 2023 | | 2023 |
| BlogsUGR como instrumento divulgativo de los TFMs del Máster en Investigación, Desarrollo, Control e Innovación de Medicamentos A Torrente López | | 2022 |
| 3PC-062 Impact of the preparation of 1.0 mg/mL nivolumab clinical solution on the particulates (aggregation) measured by dynamic light scattering: NaCl and glucose … A Torrente-López, JH Fernández, D Muñoz-Prieto, J Hernández-Jiménez, ... European Journal of Hospital Pharmacy 28 (Suppl 1), A18-A18, 2021 | | 2021 |
| 3PC-065 Impact of light stress on the isoform profile of nivolumab (Opdivo) in opened vials estimated by (RP) UHPLC-UV-(HESI/Orbitrap)-MS A Torrente-López, J Hermosilla-Fernández, J Hernández-Jiménez, ... European Journal of Hospital Pharmacy 28 (Suppl 1), A19-A20, 2021 | | 2021 |
